EcoDrugPlus

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSCAFG00020014936
Gene Symbol: FAU
3 Cross references
246 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCAFG00020018907
Gene Symbol: FYN
3 Cross references
264 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSCAFG00020001070
Gene Symbol: GPR119
3 Cross references
176 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSCAFG00020020589
Gene Symbol: GPR84
3 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCAFG00020004327
Gene Symbol: HCK
3 Cross references
206 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSCAFG00020023983
Gene Symbol: ITK
3 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSCAFG00020018270
Gene Symbol: JAK1
3 Cross references
238 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSCAFG00020001020
Gene Symbol: JAK2
3 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSCAFG00020011827
Gene Symbol: JAK3
3 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCAFG00020001613
Gene Symbol: KIT
3 Cross references
211 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSCAFG00020012793
Gene Symbol: KRAS
3 Cross references
204 Possible Orthologues:

Lck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCAFG00020025358
Gene Symbol: LCK
3 Cross references
120 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).